• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin Virol . Influenza C virus in U.S. children with acute respiratory infection 2016-2019

tetano

Editor, Senior Moderator
J Clin Virol


. 2024 Aug 8:174:105720.
doi: 10.1016/j.jcv.2024.105720. Online ahead of print. Influenza C virus in U.S. children with acute respiratory infection 2016-2019

Bethany K Sederdahl[SUP] 1 [/SUP], Geoffrey A Weinberg[SUP] 2 [/SUP], Angela P Campbell[SUP] 3 [/SUP], Rangaraj Selvarangan[SUP] 4 [/SUP], Jennifer E Schuster[SUP] 5 [/SUP], Joana Y Lively[SUP] 6 [/SUP], Samantha M Olson[SUP] 7 [/SUP], Julie A Boom[SUP] 8 [/SUP], Pedro A Piedra[SUP] 9 [/SUP], Natasha B Halasa[SUP] 10 [/SUP], Laura Stewart[SUP] 10 [/SUP], Peter G Szilagyi[SUP] 2 [/SUP], G K Balasubramani[SUP] 11 [/SUP], Theresa Sax[SUP] 11 [/SUP], Judith M Martin[SUP] 1 [/SUP], Robert W Hickey[SUP] 1 [/SUP], Marian G Michaels[SUP] 1 [/SUP], John V Williams[SUP] 12 [/SUP]; New Vaccine Surveillance Network



Affiliations
Abstract

Influenza C virus (ICV) is an orthomyxovirus related to influenza A and B, yet due to few commercial assays, epidemiologic studies may underestimate incidence of ICV infection and disease. We describe the epidemiology and characteristics of ICV within the New Vaccine Surveillance Network (NVSN), a Centers for Disease Control and Prevention (CDC)-led network that conducts population-based surveillance for pediatric acute respiratory illness (ARI). Nasal or/combined throat swabs were collected from emergency department (ED) or inpatient ARI cases, or healthy controls, between 12/05/2016-10/31/2019 and tested by molecular assays for ICV and other respiratory viruses. Parent surveys and chart review were used to analyze demographic and clinical characteristics of ICV+ children. Among 19,321 children tested for ICV, 115/17,668 (0.7 %) ARI cases and 8/1653 (0.5 %) healthy controls tested ICV+. Median age of ICV+ patients was 18 months and 88 (71.5 %) were ≤36 months. Among ICV+ ARI patients, 40 % (46/115) were enrolled in the ED, 60 % (69/115) were inpatients, with 15 admitted to intensive care. Most ICV+ ARI patients had fever (67.8 %), cough (94.8 %), or wheezing (60.9 %). Most (60.9 %) ARI cases had ≥1 co-detected viruses including rhinovirus, RSV, and adenovirus. In summary, ICV detection was rarely associated with ARI in children, and most ICV+ patients were ≤3 years old with co-detected respiratory viruses.





 
Back
Top Bottom